Hu Z, Liu W, Liu J, Zhou H, et al. The anti-tumor efficacy of a recombinant oncolytic herpes simplex virus mediated CRISPR/Cas9 delivery targeting in HPV16-positive cervical cancer. Antiviral Res 2024 Nov 11:106035. doi: 10.1016/j.antiviral.2024.106035.
PMID: 39536909